Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RMD

Resmed Inc.

Dec 06 • 04:00PM ET

164.00

Dollar change +3.05
Percentage change 1.90	%

Healthcare • Medical Instruments & Supplies • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	S&P 500	P/E	26.68	EPS (ttm)	6.15	Insider Own	0.82%	Shs Outstand	147.06M	Perf Week	3.24%
Market Cap	24.12B	Forward P/E	20.30	EPS next Y	8.08	Insider Trans	-3.49%	Shs Float	145.89M	Perf Month	6.58%
Income	906.50M	PEG	2.30	EPS next Q	1.78	Inst Own	61.35%	Short Float / Ratio	4.32% / 4.14	Perf Quarter	8.97%
Sales	4.38B	P/S	5.51	EPS this Y	12.24%	Inst Trans	-0.39%	Short Interest	6.31M	Perf Half Y	-23.64%
Book/sh	28.90	P/B	5.67	EPS next Y	11.78%	ROA	15.21%	Target Price	188.67	Perf Year	-25.23%
Cash/sh	1.42	P/C	115.36	EPS next 5Y	11.60%	ROE	23.60%	52W Range	132.24 - 243.52	Perf YTD	-21.20%
Dividend	1.94	P/FCF	29.63	EPS past 5Y	22.66%	ROI	15.86%	52W High	-32.65%	Beta	0.59
Dividend %	1.18%	Quick Ratio	1.75	Sales past 5Y	12.58%	Gross Margin	54.13%	52W Low	24.02%	ATR	4.09
Employees	10140	Current Ratio	2.99	Sales Q/Q	16.00%	Oper. Margin	26.62%	RSI (14)	69.15	Volatility	1.91% 2.50%
Optionable	Yes	Debt/Eq	0.35	EPS Q/Q	4.00%	Profit Margin	20.72%	Rel Volume	0.70	Prev Close	160.95
Shortable	Yes	LT Debt/Eq	0.34	Earnings	Oct 26 AMC	Payout	28.91%	Avg Volume	1.52M	Price	164.00
Recom	1.70	SMA20	7.77%	SMA50	11.13%	SMA200	-14.07%	Volume	1,116,154	Change	1.90%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$180 → $169
Oct-12-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$273 → $202
Oct-09-23	Upgrade	JP Morgan	Neutral → Overweight	$210 → $170
Sep-29-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-06-23	Upgrade	Needham	Hold → Buy	$180
Sep-05-23	Downgrade	UBS	Buy → Neutral	$265 → $170
Aug-01-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$262 → $284
May-23-23	Initiated	UBS	Buy	$290
Apr-14-23	Initiated	Mizuho	Buy	$255
Jan-17-23	Upgrade	JP Morgan	Neutral → Overweight	$245
Oct-28-22	Downgrade	Citigroup	Buy → Neutral
Oct-20-22	Upgrade	BofA Securities	Neutral → Buy	$245 → $260
Oct-12-22	Initiated	Jefferies	Hold
Sep-08-22	Upgrade	Citigroup	Neutral → Buy
Aug-15-22	Downgrade	CLSA	Buy → Outperform
Aug-12-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$246 → $252
Aug-12-22	Downgrade	JP Morgan	Overweight → Neutral
Aug-12-22	Downgrade	Citigroup	Buy → Neutral
Jun-06-22	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$233 → $244
Apr-06-22	Initiated	Wolfe Research	Outperform	$280

Show Previous Ratings

Dec-04-23 05:43AM	Resmeds new C-suite focused on growing sleep apnea device demand: analysts (MedTech Dive)
Nov-30-23 11:05AM	Insider Sell: CFO Brett Sandercock Sells 3,000 Shares of ResMed Inc (RMD) (GuruFocus.com)
Nov-12-23 11:45PM	Resmed overhauls C-suite, creating 3 posts and parting ways with 2 execs (MedTech Dive)
Nov-09-23 04:05PM	ResMed Adopts New Operating Model to Accelerate Long-term Growth (GlobeNewswire)
Nov-07-23 05:14AM	ResMed Inc's Dividend Analysis (GuruFocus.com)
05:05AM	Loading…
05:05AM	2 Monster Stocks to Buy Without Any Hesitation (Motley Fool)
Nov-02-23 11:15AM	MatrixCare's Electronic Health Record Platform to Deliver Operational Efficiency and Improved Clinical Outcomes Across 140 Saber Healthcare Group Affiliated Communities (GlobeNewswire)
Oct-30-23 05:38PM	Health Care Roundup: Market Talk (The Wall Street Journal)
06:51AM	Resmed cuts 5% of staff amid profitability push (MedTech Dive)
Oct-27-23 12:54PM	Analyst Report: ResMed Inc. (Morningstar Research)
12:09PM	ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:19AM	Q1 2024 Resmed Inc Earnings Call (Thomson Reuters StreetEvents)
08:01AM	ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down (Zacks)
Oct-26-23 06:11PM	ResMed Inc (RMD) Announces Q1 2024 Earnings: Revenue Growth and Strong Global Demand (GuruFocus.com)
06:00PM	ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:30PM	Loading…
05:30PM	ResMed (RMD) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:25PM	ResMed: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024 (GlobeNewswire)
Oct-19-23 10:01AM	ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-17-23 02:01PM	MedTech Earnings in the Age of Ozempic May Not Be That Bad (Barrons.com)
Oct-12-23 09:49AM	Target upgraded, Beyond Meat downgraded: Wall Street's top analyst calls (The Fly) -5.50%
Oct-09-23 11:15AM	ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes (Zacks)
Oct-05-23 04:05PM	ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023 (GlobeNewswire)
11:35AM	ResMed (RMD): Is the Stock Significantly Undervalued? An In-Depth Analysis (GuruFocus.com)
Oct-03-23 08:56AM	Here's Why Investors Should Retain ResMed (RMD) Stock for Now (Zacks)
Sep-29-23 04:20PM	Weight-Loss Drugs Divide Wall Street on Medical Device Stocks (Bloomberg)
09:40AM	Brinker upgraded, Berkshire Hathaway downgraded: Wall Street's top analyst calls (The Fly)
Sep-28-23 06:03AM	ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar? (Zacks)
Sep-26-23 12:04PM	ResMed Inc (RMD): A Deep Dive into Financial Metrics and Competitive Strengths (GuruFocus.com)
11:34AM	ResMed (RMD)'s Hidden Bargain: An In-Depth Look at the 25% Margin of Safety Based on its Valuation (GuruFocus.com)
09:45AM	Loading…
Sep-25-23 09:45AM	ResMed (RMD) Gains From Mask Sales Amid Macro Headwinds (Zacks)
Sep-21-23 09:25AM	Weight-Loss Drugs Like Wegovy Are Bad News for These Stocks (Barrons.com)
09:25AM	Weight-Loss Drugs Like Ozempic Are Bad News for These Stocks (Barrons.com)
01:00AM	Weight-Loss Drugs Are Bad News for Companies That Treat Obesity Complications (Barrons.com)
Sep-13-23 08:27AM	3 Top Growth Stock Picks Trading at a Massive Bargain (InvestorPlace)
Sep-11-23 12:33PM	ResMed (RMD): An Uncovered Gem? Unveiling Its True Value (GuruFocus.com)
12:06PM	ResMed Inc (RMD): A Deep Dive into Financial Metrics and Competitive Strengths (GuruFocus.com)
Sep-08-23 12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Sep-06-23 09:36AM	Constellation Brands upgraded, Block downgraded: Wall Street's top analyst calls (The Fly)
Sep-05-23 04:05PM	ResMed Announces Participation in Upcoming Conferences (GlobeNewswire)
12:33PM	ResMed (RMD): A Hidden Gem in the Medical Devices Industry? An In-Depth Look at Its Valuation (GuruFocus.com)
12:03PM	ResMed Inc (RMD): A Deep Dive into Financial Metrics and Competitive Strengths (GuruFocus.com)
10:06AM	Lowe's upgraded, General Mills downgraded: Wall Street's top analyst calls (The Fly)
Sep-01-23 06:21AM	3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy (Motley Fool)
Aug-28-23 09:48PM	Late-Summer Steals: 7 Stocks to Buy Before Fall (InvestorPlace)
Aug-25-23 08:15AM	3 Growth Stocks That Can Soar 50%, According to Wall Street (Motley Fool)
Aug-22-23 09:43AM	Here's Why Investors Should Retain ResMed (RMD) Stock for Now (Zacks)
Aug-21-23 04:26PM	Buy the Drop: 3 Stocks to Snag After This Months 20% Tumble (InvestorPlace)
12:08PM	ResMed Inc: A Deep Dive into Its Financial Metrics and Competitive Strengths (GuruFocus.com)
Aug-18-23 08:58PM	Analyst Report: ResMed Inc. (Morningstar Research)
Aug-15-23 12:33PM	Is ResMed (RMD) Significantly Undervalued? A Comprehensive Valuation Analysis (GuruFocus.com)
09:44AM	2 Stocks That Could Grow Your Portfolio Over the Next Decade (Motley Fool)
Aug-11-23 06:06AM	Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend? (Simply Wall St.)
Aug-08-23 12:39PM	Is ResMed Inc (RMD) Significantly Undervalued? (GuruFocus.com)
Aug-07-23 01:12PM	ResMed Inc: A High-Performing Stock with a GF Score of 98 (GuruFocus.com)
12:33PM	ResMed (RMD): A Significantly Undervalued Gem in the Medical Devices Industry? (GuruFocus.com)
Aug-06-23 10:24AM	ResMed Inc. (NYSE:RMD) Shares Could Be 31% Above Their Intrinsic Value Estimate (Simply Wall St.)
07:29AM	10 Oversold Growth Stocks To Buy (Insider Monkey)
Aug-04-23 05:22PM	S&P 500 Gains and Losses Today: Stocks Lose Ground as Hiring Slows (Investopedia) -18.50%
01:04PM	ResMed Inc. (NYSE:RMD) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:20PM	ResMed's (RMD) Q4 Earnings Miss, Revenues Beat Estimates (Zacks)
03:29AM	Analyst Report: ResMed Inc. (Morningstar Research)
Aug-03-23 08:00PM	Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics (Zacks)
05:55PM	ResMed (RMD) Misses Q4 Earnings Estimates (Zacks)
04:51PM	ResMed: Fiscal Q4 Earnings Snapshot (AP Finance)
04:05PM	ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023 (GlobeNewswire)
Aug-02-23 08:48AM	Why Earnings Season Could Be Great for ResMed (RMD) (Zacks)
01:22AM	6 big analyst picks: Citi says 'we were wrong' on AMD, calls stock a buy (Investing.com)
Aug-01-23 09:57AM	Goldman Sachs upgraded, Rivian downgraded: Wall Street's top analyst calls (The Fly)
Jul-28-23 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jul-25-23 01:48AM	Analyst Report: ResMed Inc. (Morningstar Research)
Jul-07-23 09:35AM	ResMed (RMD) Expands Solutions Portfolio With Somnoware Buyout (Zacks)
Jul-06-23 04:05PM	ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023 (GlobeNewswire)
Jul-05-23 04:05PM	ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software (GlobeNewswire)
Jun-21-23 08:00PM	RMD: Lowering target price to $228.00 (Argus Research)
Jun-15-23 10:03AM	ResMed's (RMD) New Buyout Aids Growth Amid Rising Costs (Zacks)
Jun-08-23 01:25PM	Here's Why Investors Should Retain ResMed (RMD) Stock for Now (Zacks)
09:00AM	PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP (GlobeNewswire)
Jun-06-23 02:56PM	Medical Equipment Stock to Add to Your Portfolio (Schaeffer's Investment Research)
Jun-05-23 04:05PM	ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference (GlobeNewswire)
May-29-23 11:40AM	ZBH vs. RMD: Which Stock Should Value Investors Buy Now? (Zacks)
May-25-23 09:00AM	3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 (GlobeNewswire)
May-22-23 05:43PM	Billionaire Ken Griffins 2023 Portfolio: Top 15 Stock Picks (Insider Monkey)
May-17-23 10:57AM	ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company (Simply Wall St.)
May-15-23 06:54AM	Daily Vickers Top Buyers & Sellers for 05/15/2023 (Argus Research)
May-03-23 08:59AM	With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case (Simply Wall St.)
May-02-23 04:05PM	ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer (GlobeNewswire)
May-01-23 03:15PM	Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge (Investor's Business Daily)
Apr-28-23 09:16AM	ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates (Zacks) +6.95%
08:19AM	Analyst Report: ResMed Inc. (Morningstar Research)
Apr-27-23 05:45PM	ResMed (RMD) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:05PM	ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023 (GlobeNewswire)
Apr-26-23 08:00PM	RMD: Raising target price to $235.00 (Argus Research)
Apr-06-23 04:05PM	ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023 (GlobeNewswire)
10:23AM	ResMed Inc.'s (NYSE:RMD) Stock Been Rising: Are Strong Financials Guiding The Market? (Simply Wall St.)
Mar-30-23 04:05PM	ResMed Chief Administrative Officer and Global General Counsel to Retire (GlobeNewswire)
Mar-22-23 08:45AM	3 Incredible Growth Stocks to Buy Right Now (Motley Fool)
Mar-16-23 10:49AM	Reasons Why You Should Retain ResMed (RMD) Stock For Now (Zacks)
Mar-15-23 04:19PM	ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum (GlobeNewswire)
Mar-13-23 07:00AM	ResMeds Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep (GlobeNewswire)

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sandercock Brett	Chief Financial Officer	Nov 27	Sale	152.62	3,000	457,860	92,962	Nov 29 07:45 PM
Farrell Michael J.	Chief Executive Officer	Nov 15	Option Exercise	57.76	5,678	327,961	446,664	Nov 16 09:20 PM
Farrell Michael J.	Chief Executive Officer	Nov 15	Sale	152.04	5,678	863,281	440,986	Nov 16 09:20 PM
Rider Michael J	Global General Counsel	Nov 01	Sale	143.42	25	3,585	7,358	Nov 02 09:29 PM
Farrell Michael J.	Chief Executive Officer	Oct 16	Option Exercise	57.76	5,675	327,788	455,035	Oct 17 06:50 PM
Farrell Michael J.	Chief Executive Officer	Oct 16	Sale	140.70	5,675	798,464	449,360	Oct 17 06:50 PM
Rider Michael J	Global General Counsel	Oct 02	Sale	145.92	25	3,648	7,383	Oct 04 10:57 AM
Farrell Michael J.	Chief Executive Officer	Sep 15	Option Exercise	57.76	5,675	327,788	455,035	Sep 19 02:54 PM
Farrell Michael J.	Chief Executive Officer	Sep 15	Sale	146.35	5,675	830,514	449,360	Sep 19 02:54 PM
Rider Michael J	Global General Counsel	Sep 01	Sale	161.15	25	4,029	7,408	Sep 07 03:44 PM
Farrell Michael J.	Chief Executive Officer	Aug 15	Option Exercise	57.76	5,675	327,788	442,605	Aug 17 01:39 PM
Farrell Michael J.	Chief Executive Officer	Aug 15	Sale	183.20	5,675	1,039,647	436,930	Aug 17 01:39 PM
Douglas Robert Andrew	President and COO	Aug 15	Sale	181.01	1,500	271,515	250,526	Aug 16 01:51 PM
Rider Michael J	Global General Counsel	Aug 01	Sale	224.12	25	5,603	5,186	Aug 02 05:30 PM
Farrell Michael J.	Chief Executive Officer	Jul 17	Option Exercise	57.76	5,675	327,788	442,605	Jul 19 12:13 PM
Farrell Michael J.	Chief Executive Officer	Jul 17	Sale	221.27	5,675	1,255,686	436,930	Jul 19 12:13 PM
Douglas Robert Andrew	President and COO	Jul 17	Sale	222.22	1,500	333,330	252,026	Jul 18 05:02 PM
Ghoshal Kaushik	President, SaaS Business	Jul 13	Sale	220.00	500	110,000	11,787	Jul 14 12:26 PM
Rider Michael J	Global General Counsel	Jul 03	Sale	217.21	25	5,430	5,211	Jul 05 02:13 PM
Farrell Michael J.	Chief Executive Officer	Jun 15	Option Exercise	57.76	5,675	327,788	442,605	Jun 16 05:17 PM
Farrell Michael J.	Chief Executive Officer	Jun 15	Sale	217.39	5,675	1,233,716	436,930	Jun 16 05:17 PM
Douglas Robert Andrew	President and COO	Jun 15	Sale	216.27	1,500	324,405	253,526	Jun 20 12:02 PM
PENDARVIS DAVID	Chief Administrative Officer	Jun 05	Sale	219.79	1,500	329,685	89,729	Jun 07 12:20 PM
Ghoshal Kaushik	President, SaaS Business	Jun 02	Sale	220.00	500	110,000	12,287	Jun 06 01:18 PM
Farrell Michael J.	Chief Executive Officer	May 15	Option Exercise	57.76	5,675	327,788	442,605	May 17 02:10 PM
Farrell Michael J.	Chief Executive Officer	May 15	Sale	232.10	5,675	1,317,191	436,930	May 17 02:10 PM
Douglas Robert Andrew	President and COO	May 15	Sale	232.85	1,500	349,275	255,026	May 16 06:07 PM
Sandercock Brett	Chief Financial Officer	May 10	Sale	233.13	12,574	2,931,395	90,942	May 12 07:30 PM
Sandercock Brett	Chief Financial Officer	May 09	Sale	232.05	3,426	795,000	103,516	May 10 05:16 PM
PENDARVIS DAVID	Chief Administrative Officer	May 03	Sale	237.64	1,500	356,460	91,172	May 04 07:49 PM
Ghoshal Kaushik	President, SaaS Business	May 01	Sale	239.30	500	119,650	12,704	May 02 08:04 AM
Ghoshal Kaushik	President, SaaS Business	Apr 24	Sale	230.00	2,000	460,000	13,204	Apr 25 07:34 PM
Farrell Michael J.	Chief Executive Officer	Apr 17	Option Exercise	57.76	5,675	327,788	442,575	Apr 18 04:59 PM
Farrell Michael J.	Chief Executive Officer	Apr 17	Sale	224.23	5,675	1,272,526	436,900	Apr 18 04:59 PM
Douglas Robert Andrew	President and COO	Apr 17	Sale	224.65	1,500	336,975	256,526	Apr 18 09:10 PM
PENDARVIS DAVID	Chief Administrative Officer	Apr 03	Sale	218.23	1,500	327,345	92,672	Apr 05 03:28 PM
Ghoshal Kaushik	President, SaaS Business	Apr 03	Sale	220.00	500	110,000	15,204	Apr 05 03:26 PM
Farrell Michael J.	Chief Executive Officer	Mar 15	Option Exercise	57.76	5,675	327,788	442,575	Mar 17 12:40 PM
Farrell Michael J.	Chief Executive Officer	Mar 15	Sale	206.95	5,675	1,174,451	436,900	Mar 17 12:40 PM
Douglas Robert Andrew	President and COO	Mar 15	Sale	206.14	1,500	309,210	258,026	Mar 16 04:14 PM
PENDARVIS DAVID	Chief Administrative Officer	Mar 03	Sale	216.69	1,500	325,035	94,172	Mar 07 12:32 PM
Ghoshal Kaushik	President, SaaS Business	Mar 03	Sale	220.00	1,000	220,000	15,704	Mar 07 12:28 PM
Sandercock Brett	Chief Financial Officer	Feb 17	Sale	215.22	10,000	2,152,196	106,880	Feb 22 04:21 PM
Farrell Michael J.	Chief Executive Officer	Feb 15	Option Exercise	57.76	5,675	327,788	442,575	Feb 16 03:23 PM
Farrell Michael J.	Chief Executive Officer	Feb 15	Sale	214.83	5,675	1,219,144	436,900	Feb 16 03:23 PM
Douglas Robert Andrew	President and COO	Feb 15	Sale	213.50	1,500	320,250	261,445	Feb 16 07:12 PM
Sandercock Brett	Chief Financial Officer	Feb 13	Sale	215.00	4,000	860,000	116,880	Feb 14 01:53 PM
PENDARVIS DAVID	Chief Administrative Officer	Feb 03	Sale	224.50	1,500	336,750	95,672	Feb 06 01:55 PM
Drexler Karen	Director	Feb 02	Sale	226.58	594	134,589	7,987	Feb 03 07:30 PM
Farrell Michael J.	Chief Executive Officer	Jan 17	Option Exercise	57.76	5,675	327,788	442,575	Jan 18 04:28 PM
Farrell Michael J.	Chief Executive Officer	Jan 17	Sale	224.36	5,675	1,273,269	436,900	Jan 18 04:28 PM
Douglas Robert Andrew	President and COO	Jan 17	Sale	220.43	1,500	330,645	226,208	Jan 18 04:30 PM
PENDARVIS DAVID	Chief Administrative Officer	Jan 03	Sale	210.07	1,500	315,105	97,172	Jan 05 12:54 PM
Farrell Michael J.	Chief Executive Officer	Dec 15	Option Exercise	57.76	5,675	327,788	442,575	Dec 16 02:53 PM
Farrell Michael J.	Chief Executive Officer	Dec 15	Sale	215.63	5,675	1,223,727	436,900	Dec 16 02:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RMD

Resmed Inc.

Upgrade your FINVIZ experience